WallStSmart

Kraft Heinz Co (KHC)vsPrenetics Global Ltd (PRE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kraft Heinz Co generates 20713% more annual revenue ($24.99B vs $120.07M). KHC leads profitability with a -23.1% profit margin vs -42.0%. KHC earns a higher WallStSmart Score of 61/100 (C+).

KHC

Buy

61

out of 100

Grade: C+

Growth: 4.0Profit: 4.5Value: 7.0Quality: 4.5
Piotroski: 4/9Altman Z: 0.69

PRE

Avoid

32

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 5/9Altman Z: -0.01
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KHCUndervalued (+15.6%)

Margin of Safety

+15.6%

Fair Value

$29.61

Current Price

$25.85

$3.76 discount

UndervaluedFair: $29.61Overvalued

Intrinsic value data unavailable for PRE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KHC3 strengths · Avg: 8.7/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

PEG RatioValuation
0.998/10

Growing faster than its price suggests

Operating MarginProfitability
20.7%8/10

Strong operational efficiency at 20.7%

PRE3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
107.7%10/10

Revenue surging 107.7% year-over-year

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Areas to Watch

KHC4 concerns · Avg: 2.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

Return on EquityProfitability
-13.7%2/10

ROE of -13.7% — below average capital efficiency

Altman Z-ScoreHealth
0.692/10

Distress zone — elevated risk

Profit MarginProfitability
-23.1%1/10

Currently unprofitable

PRE4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$310.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-22.1%2/10

ROE of -22.1% — below average capital efficiency

Free Cash FlowQuality
$-12.33M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : KHC

The strongest argument for KHC centers on Price/Book, PEG Ratio, Operating Margin. PEG of 0.99 suggests the stock is reasonably priced for its growth.

Bull Case : PRE

The strongest argument for PRE centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 107.7% demonstrates continued momentum.

Bear Case : KHC

The primary concerns for KHC are Revenue Growth, Return on Equity, Altman Z-Score.

Bear Case : PRE

The primary concerns for PRE are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

KHC profiles as a turnaround stock while PRE is a hypergrowth play — different risk/reward profiles.

PRE carries more volatility with a beta of 0.25 — expect wider price swings.

PRE is growing revenue faster at 107.7% — sustainability is the question.

KHC generates stronger free cash flow (766M), providing more financial flexibility.

Bottom Line

KHC scores higher overall (61/100 vs 32/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kraft Heinz Co

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Kraft Heinz Company (KHC), commonly known as Kraft Heinz, is an American food company formed by the merger of Kraft Foods and Heinz, co-headquartered in Chicago, Illinois, and Pittsburgh, Pennsylvania.

Prenetics Global Ltd

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Prenetics Global Ltd (PRE) is an innovative health technology company that specializes in advanced genetic and diagnostic testing solutions, offering invaluable health insights to consumers and healthcare professionals alike. With a robust focus on research and development, Prenetics has built a strong international footprint through strategic partnerships and collaborations, enhancing its market visibility. As a frontrunner in personalized medicine, the company is strategically positioned to leverage the growing demand for accessible health data, presenting a compelling investment opportunity within the dynamic healthcare sector.

Want to dig deeper into these stocks?